Non-segmental Vitiligo clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).
San Francisco, California and other locations
Last updated: